| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/28/2002 | WO2002024679A1 PYRIDINE DERIVATIVES WITH IKB-KINASE (IKK-β) INHIBITING ACTIVITY |
| 03/28/2002 | WO2002024662A1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| 03/28/2002 | WO2002024661A2 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 03/28/2002 | WO2002024651A1 A process for producing 2-amino-4,6-disubstituted nicotinic acid ester analogs |
| 03/28/2002 | WO2002024650A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 03/28/2002 | WO2002024225A1 Use of immidazoquinolinamines as adjuvants in dna vaccination |
| 03/28/2002 | WO2001096336A3 6,5-fused bicyclic heterocycles |
| 03/28/2002 | WO2001064676A3 INHIBITORS OF p38-α KINASE |
| 03/28/2002 | US20020037909 Enamine derivatives |
| 03/28/2002 | US20020037904 Substituted 4,9-dihydrocyclopent a [imn] phenanthridine-5-ones, derivatives thereof and their uses |
| 03/28/2002 | US20020037896 Bicyclic compounds |
| 03/28/2002 | US20020037893 Heteroaryl diazabicycloalkanes, their preparation and use |
| 03/28/2002 | US20020037891 Novel benzo[1,8]naphthyridine derivatives, their preparation and pharmaceutical compositions which comprise them |
| 03/28/2002 | US20020037889 Imidazolidin-2-one derivatives; inhibiting bone resorption, vascular restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation, arthritis, viral disease, cancer and metastatic tumor growth |
| 03/28/2002 | US20020037888 4-imidazol-1-ylmethyl-2-(2-(2-oxo-piperidin-1-yl)-phenoxy) -benzonitrile for example; farnesyl-protein transferase inhibitors; treating cancer, benign proliferative disorder, hepatitis virus, restenosis, and polycystic kidney disease |
| 03/28/2002 | US20020037886 Muscarinic agonists |
| 03/28/2002 | US20020037254 Conjugate for differentiating between healthy and unhealthy tissue |
| 03/28/2002 | DE10046267A1 Pesticides comprising flavine derivatives, e.g. riboflavin, having chitinase inhibiting activity, useful e.g. as insecticides, acaricides, nematocides, fungicides, ectoparasticides or antifouling agents |
| 03/28/2002 | CA2423284A1 Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
| 03/28/2002 | CA2423151A1 Indole derivatives and their use as antifungal and/or antiparasitic agents |
| 03/28/2002 | CA2423071A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/28/2002 | CA2423060A1 Process for producing tricyclic fused heterocyclic derivative |
| 03/28/2002 | CA2422923A1 Pyridine derivatives with ikb-kinase (ikk-.beta.) inhibiting activity |
| 03/28/2002 | CA2422863A1 Use of immidazoquinolinamines as adjuvants in dna vaccination |
| 03/27/2002 | EP1191027A1 Fused ring system containing indole as M4 selective aza-anthracene muscarinic receptor antagonists |
| 03/27/2002 | EP1189905A1 Substituted heterocycle fused gamma-carbolines |
| 03/27/2002 | EP1189904A1 Substituted heterocycle fused gamma-carbolines |
| 03/27/2002 | EP1189903A1 Novel benzo f]naphthyridine, preparation and compositions containing them |
| 03/27/2002 | EP1064284B1 Hypnotic beta-carboline derivatives, process for their preparation and their use as medicinal products |
| 03/27/2002 | EP0873336B1 Antagonists of gonadotropin releasing hormone |
| 03/27/2002 | EP0840607B1 Novel medical use |
| 03/27/2002 | EP0790996B1 Pyridazinoquinoline compounds |
| 03/27/2002 | EP0773946B1 Imidazopyridine-azolidinones |
| 03/27/2002 | CN1342161A Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 03/27/2002 | CN1342160A Crystal modification (of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-[4.3.0] nonan-8-yl)-6 Fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic |
| 03/27/2002 | CN1342157A Substituted pyrazoles ASP38 kinase inhibitors |
| 03/27/2002 | CN1342150A Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors |
| 03/27/2002 | CN1081635C Substituted pyrrolidine-3-Yl-alkyl-piperidines |
| 03/27/2002 | CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists |
| 03/26/2002 | US6362371 β2- adrenergic receptor agonists |
| 03/26/2002 | US6362208 Anilide compounds and drugs containing the same |
| 03/26/2002 | US6362191 Aminometyl oxooxazolidinyl benzene derivatives |
| 03/26/2002 | US6362189 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 03/26/2002 | US6362186 Aminoalkyl substituted 9H-phridino[2,3-b] indole and 9H-pyrimidino[4,5-b] indole derivatives |
| 03/26/2002 | US6362180 Antagonist to corticotropin releasing factor |
| 03/26/2002 | US6362134 Controlling plant growth |
| 03/26/2002 | US6361815 Isolation of purified product comprising 85% by weight of 3,4',5-trihydroxy-trans-stilbene from plant material containing trihydroxystilbenes and glycosylated derivatives thereof |
| 03/22/2002 | CA2357306A1 Fused ring system containing indole as m4 selective aza-anthracene muscarinic receptor antagonists |
| 03/21/2002 | WO2002022618A1 Method for preparing camptothecin and its derivatives |
| 03/21/2002 | WO2002022616A2 Alpha v integrin receptor antagonists |
| 03/21/2002 | WO2002022615A1 Alpha v integrin receptor antagonists |
| 03/21/2002 | WO2002022611A2 Caspase inhibitors and uses thereof |
| 03/21/2002 | WO2002022608A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022607A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022606A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022605A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022604A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022603A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022602A2 Triazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022601A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022600A2 Chemokine receptor binding heterocyclic compounds |
| 03/21/2002 | WO2002022599A2 Chemokine receptor binding heterocyclic compounds |
| 03/21/2002 | WO2002022598A1 Quinolinone derivatives as tyrosine kinase inhibitors |
| 03/21/2002 | WO2002022577A2 Hydroxamate derivatives useful as deacetylase inhibitors |
| 03/21/2002 | WO2002022574A1 Tricyclic heterocyclic compound, process for producing the same, and use thereof |
| 03/21/2002 | WO2002022125A1 Methods for delaying recurrence of herpes virus symptoms |
| 03/21/2002 | WO2002022123A1 Alpha v integrin receptor antagonists |
| 03/21/2002 | WO2001074813A3 METHOD FOR USING 2- OR 3-ARYL SUBSTITUTED IMIDAZO[1,2-a] PYRIDINES AS H3 ANTAGONISTS |
| 03/21/2002 | US20020035256 Novel synthesis of piperazine ring |
| 03/21/2002 | US20020035121 Aryl fused substituted 4-oxy-pyridines |
| 03/21/2002 | US20020035120 Oxo-imidazopyridine-carboxamides |
| 03/21/2002 | US20020035114 Substituted dimeric compounds |
| 03/21/2002 | US20020035111 Regulating apoptosis using compounds such as (6R,12aR)-2,3,6,7,12,12a-Hexahydro-6-(5-benzofuranyl)-2-methyl-pyrazino (2',1':6,1)pyrido(3,4-b)indole-1,4-dione; not having severe side reactions of conventional chemotherapeutics |
| 03/21/2002 | US20020035094 Substituted pyridine compounds and methods of use |
| 03/21/2002 | US20020035057 Treatment of movement disorders by administration of 5-hydroxytryptamine receptor/alpha2 adrenergic receptor antagonist compositions |
| 03/21/2002 | CA2422841A1 Methods for delaying recurrence of herpes virus symptoms |
| 03/21/2002 | CA2421792A1 Alpha v integrin receptor antagonists |
| 03/21/2002 | CA2421652A1 Alpha v integrin receptor antagonists |
| 03/21/2002 | CA2419224A1 Chemokine receptor binding heterocyclic compounds |
| 03/21/2002 | CA2419219A1 Chemokine receptor binding heterocyclic compounds |
| 03/21/2002 | CA2418720A1 Caspase inhibitors and uses thereof |
| 03/20/2002 | EP1188744A1 Process for producing 1H-3-aminopyrrolidine and derivatives thereof |
| 03/20/2002 | EP1188439A2 Cell differentiation induction with mevalonate and mevalonolactone derivatives |
| 03/20/2002 | EP1187835A1 Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof |
| 03/20/2002 | EP1187813A1 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 03/20/2002 | EP1187812A2 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
| 03/20/2002 | EP1187616A1 Thrombin inhibitors |
| 03/20/2002 | EP1187614A1 Substituted piperidines as melanocortin-4 receptor agonists |
| 03/20/2002 | EP1187613A1 Amide substituted imidazoquinolines |
| 03/20/2002 | EP1187592A2 Alpha v integrin receptor antagonists |
| 03/20/2002 | EP0837860B1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO(3,4-c]-1,2,4-TRIAZOLO(4,3-ALPHA]PYRIDINES |
| 03/20/2002 | CN1341116A Crystal modification D of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-[4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid |
| 03/19/2002 | US6359137 Antibiotic |
| 03/19/2002 | US6359136 Antithrombotic agents |
| 03/19/2002 | US6359122 Quinacridone, indigo, dioxazine or azo dyes |
| 03/19/2002 | US6358979 N-cyclopentyl modulators of chemokine receptor activity |
| 03/19/2002 | US6358978 Substituted benzimidazoles |
| 03/19/2002 | US6358976 For therapy and prophylaxis of cancer metastasis, diabetic retinopathy, neovascular glaucoma, thrombosis, restenosis, osteoporosis, or macular degeneration |
| 03/19/2002 | US6358974 Used as as modulators of dopamine d.sub.3 receptors, in therapy as antipsychotic agents |
| 03/19/2002 | US6358972 5-HT1F agonists |